Literature DB >> 2100414

Effects of oral pyridoxine upon plasma and 24-hour urinary oxalate levels in normal subjects and stone formers with idiopathic hypercalciuria.

P Edwards1, S Nemat, G A Rose.   

Abstract

The effect of pyridoxine hydrochloride, 200 mg/day (0.97 mmol/day) for 3 weeks, upon plasma and urinary oxalate has been determined in ten normal subjects and seven patients with idiopathic hypercalciuria while both groups were on low-oxalate diets. Patients had higher basal urinary oxalate levels than normal subjects. In normal subjects pyridoxine administration decreased plasma oxalate levels and raised urinary oxalate. The patients showed no change in either plasma or urinary oxalate.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2100414     DOI: 10.1007/bf00297371

Source DB:  PubMed          Journal:  Urol Res        ISSN: 0300-5623


  20 in total

1.  Vitamin B6 deficiency and oxalate nephrocalcinosis in the cat.

Authors:  S N GERSHOFF; F F FARAGALLA; D A NELSON; S B ANDRUS
Journal:  Am J Med       Date:  1959-07       Impact factor: 4.965

2.  Treatment of primary hyperoxaluria.

Authors:  L H Smith; H E Williams
Journal:  Mod Treat       Date:  1967-05

3.  Some factors influencing the urinary excretion of oxalic acid in man.

Authors:  P M Zarembski; A Hodgkinson
Journal:  Clin Chim Acta       Date:  1969-07       Impact factor: 3.786

4.  Measurement of plasma oxalate in healthy subjects and in patients with chronic renal failure using immobilised oxalate oxidase.

Authors:  G P Kasidas; G A Rose
Journal:  Clin Chim Acta       Date:  1986-01-15       Impact factor: 3.786

5.  A new enzymatic method for the determination of glycollate in urine and plasma.

Authors:  G P Kasidas; G A Rose
Journal:  Clin Chim Acta       Date:  1979-08-15       Impact factor: 3.786

6.  Urinary oxalate in summer and winter in normal subjects and in stone-forming patients with idiopathic hypercalciuria, both untreated and treated with thiazide and/or cellulose phosphate.

Authors:  P C Hallson; G P Kasidas; G A Rose
Journal:  Urol Res       Date:  1976

7.  Proximal tubular defects in idiopathic hypercalciuria: resistance to phosphate administration.

Authors:  Y K Lau; A Wasserstein; G R Westby; P Bosanac; M Grabie; P Mitnick; E Slatopolsky; S Goldfarb; Z S Agus
Journal:  Miner Electrolyte Metab       Date:  1982

8.  Effect of high-calcium diet on urinary oxalate excretion in urinary stone formers.

Authors:  T Nakada; I Sasagawa; H Furuta; T Katayama; J Shimazaki
Journal:  Eur Urol       Date:  1988       Impact factor: 20.096

9.  The cause of idiopathic calcium stone disease: hypercalciuria or hyperoxaluria?

Authors:  W G Robertson; M Peacock
Journal:  Nephron       Date:  1980       Impact factor: 2.847

10.  The diurnal urinary excretion of oxalate and the effect of pyridoxine and ascorbate on oxalate excretion.

Authors:  H G Tiselius; L E Almgård
Journal:  Eur Urol       Date:  1977       Impact factor: 20.096

View more
  4 in total

1.  Effect of blind treatment on stone disease.

Authors:  Y M Fazil Marickar; Abiya Salim; Adarsh Vijay
Journal:  Urol Res       Date:  2009-12-08

2.  Vitamin B6 intake and the risk of incident kidney stones.

Authors:  Pietro Manuel Ferraro; Eric N Taylor; Giovanni Gambaro; Gary C Curhan
Journal:  Urolithiasis       Date:  2017-07-03       Impact factor: 3.436

3.  Diet-Derived Antioxidants and Risk of Kidney Stone Disease: Results From the NHANES 2007-2018 and Mendelian Randomization Study.

Authors:  Zhongyu Jian; Menghua Wang; Xi Jin; Hong Li; Kunjie Wang
Journal:  Front Nutr       Date:  2021-12-21

Review 4.  Improving Treatment Options for Primary Hyperoxaluria.

Authors:  Bernd Hoppe; Cristina Martin-Higueras
Journal:  Drugs       Date:  2022-07-02       Impact factor: 11.431

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.